It is not enough only to prepare a standard plan of the product launch for the CIS countries by employing this standard tools and techniques. We bring to our work extensive international experience in this field, which is used by Big Pharma companies during the product launch of both, innovative and generic products.
The world has changed, business realities have changed even more. Today, all established concepts of bringing new pharma products to market are no longer as productive as yesterday. Regulatory volatility, patients' expectations, and opinion leaders behavior, the impact of information technology continue to change the reality even more radically.
Our service includes the development of integrated solutions for the New Product Launch across the CIS countries and contains the following sections:
|COMMERCIAL MODEL DEVELOPMENT||OPERATIONAL AND MARKETING COSTING|
|MARKETING AND BRAND PLANNING||MARKET ACCESS TIMELINE DEVELOPMENT|
We conduct a comprehensive assessment of regulatory barriers and peculiarities of regulatory systems before accessing the market. In particular:
Due to the close partnership with law firms in Ukraine, Russia, and the CEE/CIS countries, we offer a complete integrated analysis solution for a regulatory environment while entering a new market.
Consulting in the field of marketing analysis, access to markets, and P&R, stakeholders mapping etc.
Please contact Eugene Brovko tel.: +380 (44) 232-11-42 or via e-mail: EBrovko@upharma-c.com to clarify all questions regarding Market Access services.
Leave your message